000 | 01703 a2200469 4500 | ||
---|---|---|---|
005 | 20250513040109.0 | ||
264 | 0 | _c19930318 | |
008 | 199303s 0 0 eng d | ||
022 | _a0085-2538 | ||
024 | 7 |
_a10.1038/ki.1993.24 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaragoudakis, M E | |
245 | 0 | 0 |
_aBasement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties. _h[electronic resource] |
260 |
_bKidney international _cJan 1993 |
||
300 |
_a147-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- _xanalogs & derivatives |
650 | 0 | 4 |
_aAllantois _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBasement Membrane _xdrug effects |
650 | 0 | 4 |
_aBridged-Ring Compounds _xpharmacology |
650 | 0 | 4 |
_aCarcinoma 256, Walker _xblood supply |
650 | 0 | 4 | _aChick Embryo |
650 | 0 | 4 |
_aChorion _xdrug effects |
650 | 0 | 4 |
_aCollagen _xbiosynthesis |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xmetabolism |
650 | 0 | 4 | _aNorbornanes |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aThiocarbamates |
650 | 0 | 4 |
_aThiones _xpharmacology |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
700 | 1 | _aMissirlis, E | |
700 | 1 | _aKarakiulakis, G D | |
700 | 1 | _aSarmonica, M | |
700 | 1 | _aBastakis, M | |
700 | 1 | _aTsopanoglou, N | |
773 | 0 |
_tKidney international _gvol. 43 _gno. 1 _gp. 147-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ki.1993.24 _zAvailable from publisher's website |
999 |
_c7678880 _d7678880 |